Glial cells play crucial roles in brain homeostasis and pathogenesis of central nervous
system (CNS) injuries and diseases. However, the roles of these cells and the molecular …

Background and Objectives Masitinib is a selective tyrosine kinase inhibitor, targeting innate
immune cells (mast cells and microglia) that are involved in the pathophysiology of …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
(CNS) resulting in demyelination and neurodegeneration. The therapeutic strategy is now …

Objectives Magnetic resonance imaging (MRI) is an important tool for diagnosis and
monitoring of disease course in multiple sclerosis (MS). However, its prognostic value for …

Autologous haematopoietic stem cell transplantation (aHSCT) is gaining traction as a
valuable treatment option for patients affected by severe multiple sclerosis (MS), particularly …

Background and Objectives Large-scale observational studies have shown that, in patients
with multiple sclerosis (MS), the risk of becoming more severely ill from coronavirus disease …

Comorbidities in patients with multiple sclerosis (MS) and antibody-mediated diseases of the
central nervous system (CNS) including neuromyelitis optica spectrum disorder (NMOSD) …

Background Multiple sclerosis (MS)‐linked stress is frequent, multidetermined and facilitates
the onset/exacerbation of MS. However, few explanatory models of stress analysed the joint …

Primary progressive multiple sclerosis (PPMS), the least frequent type of multiple sclerosis
(MS), is characterized by a specific course and clinical symptoms, and it is associated with a …

This article describes the rationale for the development of the MSProDiscuss™ clinical
decision support (CDS) tool, its development, and insights into how it can help neurologists …